Next Capital Management’s GSK GSK Stock Holding History

Next Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-159	Closed	-$8K	–	472
2019 Q2	$8K	Buy	+159	New	+$7.98K	0.01%	495

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Next Capital Management's GSK Position: Q3 2019 in Review

Next Capital Management sold out of GSK (GSK) in Q3 2019, closing a stake of 159 shares — an estimated $8K sold.

Next Capital Management first reported a position in GSK in Q2 2019 and held it in 1 quarter. The position peaked at $8K in Q2 2019. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Next Capital Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
Next Capital Management sold 159 GSK shares in Q3 2019, an estimated $8K.
Next Capital Management first reported a position in GSK in Q2 2019 and held it in 1 quarter.
Next Capital Management's GSK position peaked at $8K in Q2 2019.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.